Brief: Everest Medicines Says CBC Group Buys 690,000 Co Shares For HK$20 MLN
04/06/2026 24:20
BRIEF-Everest Medicines Says CBC Group Buys 690,000 Co Shares For HK$20 MLN June 4 (Reuters) - Everest Medicines Ltd 1952.HK:
CBC GROUP PURCHASES 690,000 EVEREST MEDICINES SHARES FOR HK$20 MILLION AT HK$28.93 PER SHARE
Further company coverage: 1952.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Everest Medicines
See all newsBrief: Everest Medicines Says NMPA Approves Cardamyst (Etripamil) NDA For PSVT In Adults In China
Brief: Everest Medicines Enters Commercialization Collaboration With Hainan Herui Pharmaceutical
Brief: Everest Medicines Says CBC Group Purchases 712,000 Everest Medicines Shares For Hk$19.2 Million From 16 To 17 June
Australia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region